Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor
about
Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to reninRecycling of the urokinase receptor upon internalization of the uPA:serpin complexesExpression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitroEarly increases in plasminogen activator activity following partial hepatectomy in humansTargeting the Notch signaling pathway in cancer therapeuticsVEGF-initiated angiogenesis and the uPA/uPAR systemThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsBradykinin: Inflammatory Product of the Coagulation SystemBeta-catenin--a linchpin in colorectal carcinogenesis?Histone H2B as a functionally important plasminogen receptor on macrophagesProteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activationTyrosine-kinase inhibition results in EGFR clustering at focal adhesions and consequent exocytosis in uPAR down-regulated cells of head and neck cancers.Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.Urokinase-type plasminogen activator supports liver repair independent of its cellular receptoruPA is upregulated by high dose celecoxib in women at increased risk of developing breast cancer.Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility.Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Probing binding and cellular activity of pyrrolidinone and piperidinone small molecules targeting the urokinase receptor.New insights into the role of Plg-RKT in macrophage recruitment.Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growthDown-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cellsCell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cellsElongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasionUrokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.A cyclic peptidic serine protease inhibitor: increasing affinity by increasing peptide flexibilityDiabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway.Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteinsDecoy plasminogen receptor containing a selective Kunitz-inhibitory domain.Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpressionMaspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesionRegulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cellsUrokinase type plasminogen activator receptor expression in colorectal neoplasms.Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT.A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction
P2860
Q24298747-64A94420-95D1-4B7E-8F9A-8BAA3451481CQ24532196-D98B8021-8227-4E26-B93E-B3B2484D11D7Q24792833-014DAFB1-1B33-4C91-9150-EE43F85B5D04Q24802907-531A2942-E54D-4E43-A7D8-7B2B0E79C1A7Q26863580-67B82619-D16B-472A-B4EF-D460FBC3A21FQ27025897-8BE651F5-A138-44AD-BE7E-7F26570DAA2DQ28066752-1DE9FB70-CE33-4681-8BDB-1690151C57E2Q28072738-50C4FB03-49F0-4EBA-AE14-D5B77823B24CQ28198211-33C8CCE5-155E-4CB8-B721-2E28BD349D6DQ28513058-9E3BA348-99AC-452B-9B1D-C37F9888667DQ28591912-C71AAFAB-BA3C-49BD-873C-2B9EEC22F598Q30482688-19BFDFC7-D568-43E8-A57C-A997B7D13467Q30491518-CEB7314B-F3FE-4812-A798-1A1E81C6569BQ33264968-FC0D4F4D-A71A-4B63-BBE5-7F4B1CB48276Q33376876-3397076E-9780-49BF-97EB-3294EB9A753EQ33615358-FAED724E-F568-44A4-8ADD-DFA8CDB11693Q33741426-7A018B92-417E-4674-9AC4-0CDCE4549450Q33758094-ED70A052-D351-4FBD-8F56-9FBAFC4FF7BFQ33768031-DEE0A6CD-2266-4DC0-96FA-954C39FB4F2FQ33867384-8A689ADD-6905-48BB-941F-50E51D26DADEQ33886514-389481E8-B896-422E-AE77-8719087BC9FAQ34075406-3D17A59A-C070-4E1D-891F-D4B8AE60BF1EQ34075485-08DD4987-CEFC-4851-A32A-067F2E4FE92BQ34109699-04F6EF0F-CF25-4B13-88C0-BAE6800F1749Q34267846-9CCA8097-00FD-4FFE-A5FA-4F6BFD235C01Q34473662-FDF15F1C-CE54-41D0-90A4-7E966099DD1BQ34489359-D2B75B91-8F11-4776-81EA-503FD18CB023Q34766934-330E877B-F501-4327-8611-7CD2A281ADC1Q34784373-05FD696F-331B-4CB9-BA03-C71993A26155Q34950799-426CACF1-5A11-4D76-A04D-CB73CEAECC3EQ35004950-DFD3511B-C38E-48BF-9CF5-A3E68684CF3AQ35063189-C0B728A4-DC7F-480A-8E83-E82C3E7FC04EQ35079577-27B373BC-CCD0-487A-97A7-1223179E8F3BQ35098346-1695BBC4-35C9-479E-9671-AE231AB6B9A7Q35107356-4F79DC92-35E3-4F18-B7B1-1DD835E8D473Q35142158-D0B5361B-A6EE-4D7B-B4F6-E00F09BF611FQ35238060-15B0D862-B9E5-4F12-91D6-7729716E9E72Q35353534-11C4636F-CBD8-4E9E-8A11-908A81C4BA7FQ35553363-EC37CC2F-1A4D-4674-8742-B1851727D4C4Q35559411-3E2B225E-5870-49EF-A328-918B1D11F3CA
P2860
Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor
description
1991 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1991
@ast
im Juli 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1991/07/05)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd op 1991/07/05)
@nl
наукова стаття, опублікована в липні 1991
@uk
name
Plasminogen activation by rece ...... sociated and isolated receptor
@ast
Plasminogen activation by rece ...... sociated and isolated receptor
@en
Plasminogen activation by rece ...... sociated and isolated receptor
@nl
type
label
Plasminogen activation by rece ...... sociated and isolated receptor
@ast
Plasminogen activation by rece ...... sociated and isolated receptor
@en
Plasminogen activation by rece ...... sociated and isolated receptor
@nl
prefLabel
Plasminogen activation by rece ...... sociated and isolated receptor
@ast
Plasminogen activation by rece ...... sociated and isolated receptor
@en
Plasminogen activation by rece ...... sociated and isolated receptor
@nl
P2093
P3181
P1476
Plasminogen activation by rece ...... sociated and isolated receptor
@en
P2093
P304
12752–12758
P3181
P407
P577
1991-07-05T00:00:00Z